nach oben

Erschienen in:

Open Access 01.12.2015 | Research

An fMRI study of facial emotion processing in children and adolescents with 22q11.2 deletion syndrome

verfasst von: Rayna Azuma, Quinton Deeley, Linda E Campbell, Eileen M Daly, Vincent Giampietro, Michael J Brammer, Kieran C Murphy, Declan GM Murphy

Erschienen in: Journal of Neurodevelopmental Disorders | Ausgabe 1/2015

Abstract

Background

22q11.2 deletion syndrome (22q11DS, velo-cardio-facial syndrome [VCFS]) is a genetic disorder associated with interstitial deletions of chromosome 22q11.2. In addition to high rates of neuropsychiatric disorders, children with 22q11DS have impairments of face processing, as well as IQ-independent deficits in visuoperceptual function and social and abstract reasoning. These face-processing deficits may contribute to the social impairments of 22q11DS. However, their neurobiological basis is poorly understood.

Methods

We used event-related functional magnetic resonance imaging (fMRI) to examine neural responses when children with 22q11DS (aged 9–17 years) and healthy controls (aged 8–17 years) incidentally processed neutral expressions and mild (50%) and intense (100%) expressions of fear and disgust. We included 28 right-handed children and adolescents: 14 with 22q11DS and 14 healthy (including nine siblings) controls.

Results

Within groups, contrasts showed that individuals significantly activated ‘face responsive’ areas when viewing neutral faces, including fusiform-extrastriate cortices. Further, within both groups, there was a significant positive linear trend in activation of fusiform-extrastriate cortices and cerebellum to increasing intensities of fear. There were, however, also between-group differences. Children with 22q11DS generally showed reduced activity as compared to controls in brain regions involved in social cognition and emotion processing across emotion types and intensities, including fusiform-extrastriate cortices, anterior cingulate cortex (Brodmann area (BA) 24/32), and superomedial prefrontal cortices (BA 6). Also, an exploratory correlation analysis showed that within 22q11DS children reduced activation was associated with behavioural impairment—social difficulties (measured using the Total Difficulties Score from the Strengths and Difficulties Questionnaire [SDQ]) were significantly negatively correlated with brain activity during fear and disgust processing (respectively) in the left precentral gyrus (BA 4) and in the left fusiform gyrus (FG, BA 19), right lingual gyrus (BA 18), and bilateral cerebellum.

Conclusions

Regions involved in face processing, including fusiform-extrastriate cortices, anterior cingulate gyri, and superomedial prefrontal cortices (BA 6), are activated by facial expressions of fearful, disgusted, and neutral expressions in children with 22q11DS but generally to a lesser degree than in controls. Hypoactivation in these regions may partly explain the social impairments of children with 22q11DS.

Additional file 1: Table 6: Contrasts of neural responses to neutral faces versus fixation cross; Table 7. Contrasts of neural responses to intense fearful face versus fixation cross; Table 8. Contrasts of neural responses to intense disgusted face versus fixation cross. (DOC 38 KB)

Electronic supplementary material

The online version of this article (doi:10.1186/1866-1955-7-1) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RA carried out the fMRI study, analysed the data, and drafted the manuscript. QD supervised the analysis and helped to draft the manuscript. LEC participated in the design of the study and provided neuropsychological data. EMD helped the image analysis. VG and MJB created and provided the image analysis tools for the current study and also contributed to the image analysis section of the draft. KCM and DGM were in charge of the large-scale research project on the behavioural phenotype of 22q11DS of which the current study was a part. All authors read and approved the final manuscript.

22q11DS

22q11.2 deletion syndrome

ADD

attention deficit disorder

ADHD

attention deficit hyperactivity disorder

ANOVA

analysis of variance

ASD

autistic spectrum disorder

ASQ

Autism Screening Questionnaire

Brodmann area

COMT

catechol-O-methyl transferase

EPI

echoplanar imaging

fusiform gyrus

fMRI

functional magnetic resonance imaging

FSIQ

Full Scale IQ

ISI

interstimulus interval

SDQ

Strengths and Difficulties Questionnaire

VCFS

velo-cardio-facial syndrome

WISC-III

Wechsler Intelligence Scale for Children-III.

Background

22q11.2 deletion syndrome (22q11DS), also known as velo-cardio-facial syndrome (VCFS), is a genetic disorder associated with a microdeletion in chromosome 22q11.2 [1‐3]. It is the most common microdeletion syndrome with an estimated prevalence of 1 in every 4,000 live births [4‐6]. While the physical phenotype is variable, commonly reported features include characteristic facial dysmorphology, congenital heart disease, and cleft palate [7, 8]. A characteristic behavioural phenotype in 22q11DS has also been described—with high rates of schizophrenia, attention deficit (hyperactivity) disorder (ADD, ADHD) [3, 8‐13], autistic spectrum disorders, anxiety disorders, and emotional instability [12‐17]. In addition, children and adults with 22q11DS typically have mild intellectual disabilities and a characteristic cognitive profile—with particular deficits in visual-perceptual function and social and abstract reasoning [3, 17‐26]. It has been suggested by some that these cognitive deficits may contribute to the social impairments frequently observed in 22q11DS [17].

It is well established that children with 22q11DS have problems with social interaction, and perhaps, especially with peer relations rather than with adult figures [27‐29]. For instance, it has been reported that people with 22q11DS typically show a ‘bland affect’ with minimal facial expression, in addition to disinhibited and impulsive or serious and shy extremes of behaviour [17, 25, 30, 31]. Furthermore, it has been reported that 20%–50% of children and adolescents in their sample of 22q11DS exhibited some ‘autism spectrum problem [13, 16, 25, 32‐35].’ While reported prevalence of autistic spectrum disorder (ASD) among 22q11DS varies widely from study to study, it is nevertheless considerably higher than in the general population which is around 1% to 1.5% [36‐43]. Hence, impairment in social function may be a central feature of 22q11DS [44]. A recent study has reported that weaker functional connectivity between the posterior cingulate gyrus and other default mode network nodes (such as the precuneus, precentral gyrus, and left frontal pole) observed in individuals with 22q11DS was correlated with lower social competence [44]. However, cognitive and/or functional neural substrates underlying social impairment are undetermined.

The ability to perceive and respond to facial expressions is crucial to managing social interactions and relationships, and deficits in face processing have often been reported in clinical populations with social interaction problems [45, 46]. For instance, abnormalities in the expression and recognition of emotions have been reported in people with ASD [47‐49]. In 22q11DS, deficits in memory for faces have been reported [18, 50], and recent behavioural studies have shown that children and adolescents with 22q11DS have difficulties identifying faces and facial emotions [18, 51‐56]. For instance, during face identification and emotion recognition tasks, children and adolescents with 22q11DS (as compared to controls) make more errors and pay preferential attention to the mouth rather than the eyes [51, 52]. These deficits in the recognition of faces and facial emotion may reflect inefficient strategies employed by the individuals with 22q11DS and/or biological differences during facial emotion processing.

In healthy humans, face processing engages a variety of brain regions, some of which are common to all emotion types (e.g. core visual analysis areas of striate and extrastriate cortex, particularly the fusiform gyrus [FG]) [57, 58]. Core visual analysis areas project to ‘downstream’ components of face responsive systems, in which cortical and subcortical regions are differentially activated depending on stimulus features (e.g. neutral or fearful face) and cognitive task (e.g. emotion recognition) [59, 60]. Further, identification of the emotional valence of faces (and other stimuli) and the generation of emotional responses typically require activity in a predominantly ventral neural system. This includes the amygdala, insula, ventral striatum, and ventral regions of the anterior cingulate cortex and prefrontal cortex [46, 57]. Furthermore, within healthy populations, across different emotions, as emotion intensity of a facial expression increases, there is differential engagement of components of face responsive networks such as core visual analysis areas (including the FG) and limbic regions [60]. For example, the amygdala and visual cortices are co-activated in response to fearful faces. It has been proposed that visual cortex activation is boosted by ‘feedback’ influences from the amygdala [61, 62] and that this may contribute to the detection and memorization of important social cues [63]. Another structure that is implicated in the processing of emotion is the cerebellum [64‐67]. Studies have implicated the cerebellum in various aspects of emotional processing such as identification of emotion in a speaker’s voice [68], induction of positive and negative emotion [69, 70], processing of positive and negative emotional stimuli [71], and fear conditioning [72, 73]. It has been suggested that cerebellar activation may be associated with processing of ‘primitive’ emotion [74], but the exact nature of the contribution of the cerebellum to emotion processing is still unclear.

To date, two imaging studies have investigated facial emotion processing in 22q11DS. In the first functional magnetic resonance imaging (fMRI) study [75], eight adults with 22q11DS and nine age- and IQ-matched controls were scanned during an incidental (gender discrimination) task. Two types of facial emotions (happy or angry) and neutral faces were presented in a block design. Individuals with 22q11DS showed significant hypoactivation of the right insula and of the frontal regions and higher activation of the occipital regions compared to the controls. It was suggested that these findings may be partially explained by dysmaturation of white matter tracts in 22q11DS [76, 77] and may underlie social-emotional dysfunction seen in this population. However, this study employed a block design that mixed both ‘happy’ and ‘angry’ faces—making it impossible to distinguish neural responses to two very different emotions (i.e. one positive and one negative) or neutral faces.

A more recent event-related fMRI study examined brain activity in response to fearful and neutral facial expressions in young people with 22q11DS and controls during an incidental (faces/houses categorization) task [78]. The authors reported a lack of face-selective activation in FG and a lack of modulation of the amygdala and superior temporal sulcus by fearful expressions. These findings were associated with the absence of repetition-suppression effect in 22q11DS, both of which were present in the controls. The authors suggested that these functional abnormalities in the FG, amygdala, and other face-related areas may underlie social deficits in 22q11DS [78]. However, this study only employed one emotion type (fear) at a single intensity (prototypic), whereas normal social interaction involves different types of facial expressions at different intensities [60]. Further, one third of the 22q11DS group had psychotic symptoms, which may have contributed to the group differences observed in their study. For example, several studies have reported abnormal brain activity during facial emotion processing in people with psychotic illness [79‐81]; similarly, a recent study of facial emotion processing in 22q11DS reported differences in brain activations between 22q11DS volunteers with psychotic symptoms and those without [78].

In summary, previous studies point to abnormalities in the neural responses associated with processing facial expressions in 22q11DS [75, 78]. However, it is unclear whether (and how) the functional anatomy of these neural responses may differ according to different types of primary emotions and across a range of intensities. In order to address these issues, studies are required in young people without psychotic symptoms and across more than one emotion type and intensity.

We therefore employed a cross-sectional event-related design to investigate neural responses to neutral faces and to two facial emotions (fear, disgust) with high (100%) and mild (50%) emotional intensities in children and adolescents with 22q11DS. We selected fear and disgust out of the basic human emotional expressions because of their significance in the development of socialization skills. For instance, it has been suggested that individuals learn to avoid behaviours that are associated with fearful expressions as they elicit an aversive arousal response [82]. We also included disgust as it signals socially unacceptable behaviours as well as aversive stimuli (e.g. odours and/or tastes associated with rotten food) [83]. Based on previous studies, we predicted that typically developing children would show differential activation of the limbic area depending on emotion type (e.g. greater amygdala activation for fear and insula activation for disgust) [45, 46]. Given the evidence of reduced recognition of facial expressions of emotion in children with 22q11DS, we tested the main hypothesis that they would show increased limbic and visual cortical responses as emotion intensity is increased but that these responses would be significantly less than those of healthy controls for both emotion types and intensities. We also conducted exploratory correlation analysis, within the 22q11DS group, of measures of social behaviour, as measured by the Strengths and Difficulties Questionnaire (SDQ) [84‐86] and neural activity in order to determine what, if any, functional abnormalities may be associated with social difficulties in people with 22q11DS.

Methods

Participants

We studied 28 children and adolescents; 14 with 22q11DS and 14 normally developing controls. The 22q11DS group comprised seven males and seven females, aged 9–17 years (mean age ± standard deviation, 13 ± 2 years), and the healthy controls included nine males and five females, aged 8–17 years (13 ± 3 years) (see Table 1 for demographic data). Where possible, we used sibling controls in order to match for socio-cultural background. Nine of the control group were siblings, and five were recruited from the local community. All were right-handed.

Table 1

Demographic data and task performance

	22q11DS	Control	p value
	n = 14	n = 14 (9)
Age range (mean ± SD)	9–17 (13 ± 2)	8–17 (13 ± 3)	0.942
Sex: M/F	7/7	9(5)/5(4)
FSIQ (WISC-III)	66 ± 7	114 ± 16	0.000^**
PIQ (WISC-III)	67 ± 8	108 ± 19	0.000^**
VIQ (WISC-III)	70 ± 12	111 ± 16	0.000^**
ASQ	n = 12	n = 8
	6 ± 4	2 ± 3	0.048^*
ADHD index	n = 11	n = 9
	60 ± 10	48 ± 5	0.039^*
SDQ	n = 11	n = 9
Total difficulties	13.9 ± 7.1	6.2 ± 4.1	0.011^*
Emotional symptoms	3.6 ± 3.3	0.7 ± 0.7	0.117^*
Conduct problems	2.1 ± 1.6	1.6 ± 1.6	0.471
Hyperactivity	5.2 ± 3.3	3.2 ± 2.9	0.182
Peer problems	3 ± 2.7	0.8 ± 1.4	0.040^*
Prosocial behaviour^a	7.9 ± 1.6	8.6 ± 1.4	0.354
Gender discrimination task
Fear accuracy	73 ± 20	83 ± 17	0.15
Fear response time	771 ± 212	842 ± 109	0.279
Disgust accuracy	81 ± 9	83 ± 17	0.606
Disgust response time	883 ± 139	840 ± 126	0.408

Accuracy and response time for the gender discrimination task for 22q11DS group and the controls. ADHD index which is a subscale of the ‘Conners Rating Scales’ (CRS).

FSIQ full scale IQ, PIQ performance IQ, VIQ verbal IQ, ASQ Autism Screening Questionnaire, SDQ Strengths and Difficulties Questionnaire.

^*Significant at a trend level p < 0.05; ^**significant at p < 0.001; ^areverse scale.

All participants underwent psychiatric and physical examination and routine blood tests. We excluded participants with a clinically detectable co-morbid psychiatric disorder or physical disorder affecting brain function (e.g. ADHD, hypothyroidism, or epilepsy) or with a clinically abnormal MRI scan—as determined by a neuroradiologist. None of the participants had any psychotic symptoms, and all were drug free at the time of testing.

The 22q11DS volunteers were recruited through the 22q11 (UK) Support group and the Behavioural Genetics Clinic at the Maudsley Hospital/Institute of Psychiatry, King’s College London. 22q11DS was diagnosed by fluorescence in situ hybridization (FISH) using the N25 probe (Oncor Inc.). As exclusion criteria, we recruited only those who had been able to successfully complete MRI scanning for another study [87] and who had a minimum Full Scale IQ (FSIQ) of 55, as the FSIQ of children with 22q11DS tends to range from normal to moderately learning disabled with a mean FSIQ of about 70 [17, 21]. The ‘Autism Screening Questionnaire’ (ASQ) was administered in order to measure autistic traits with a cut-off score of 14 for those who may have autism and who should have a more complete assessment [88]. The ASQ score was significantly higher in the 22q11DS group than in the controls (t(18) = 2.12, p < .05), but none scored above the cut-off. We measured ADHD symptoms with the ‘Conners Rating Scales’ (CRS) [89, 90]. Among those who agreed to provide the data, children with 22q11DS scored significantly higher (60 ± 10) than the controls (48 ± 5). Further, in view of the high rates of schizotypy reported in 22q11DS adults [9], an assessment of schizotypal traits was also performed. However, since there was no validated measure for schizotypy in learning-disabled children, we constructed a preliminary comparative schizotypy scale derived from DSM-IV [91]. Of those who agreed to provide the information, 6 out of 11 children with 22q11DS scored at least one positive rating (score range 0–7, mean ± SD: 2 ± 2), whereas none of the 9 controls did. This may indicate a higher level of schizotypy traits in the VCFS sample, although the schizotypy scale itself needs to be validated. The Wechsler Intelligence Scale for Children-III (WISC-III) [92] was used to assess general intellectual function. The mean FSIQ and standard deviation for individuals with 22q11DS and controls were 66 ± 7 and 114 ± 16, respectively. All the participants and/or their parents gave written informed consent/assent as approved by the local research ethics committee (Institute of Psychiatry, South London and Maudsley Trust, 067/00).

The parent’s version of the SDQ [84‐86, 93] was used to measure emotional symptoms, conduct problems, hyperactivity, peer problems, and prosocial behaviour. The Total Difficulties Score is generated by summing the scores from all the scales except the Prosocial scale (where normal-abnormal direction of the scores is the opposite from the others). The SDQ is a well-validated behavioural screening questionnaire and the Total Difficulties Score provides an aggregate measure of difficulties in the behaviours, emotions, and relationships of children and young people.

Functional neuroimaging task

Each volunteer participated in two 6-min event-related fMRI experiments. In each experiment, participants were presented with facial expressions of one of two primary emotions (disgust, fear) and neutral expressions from a standardized series of prototypical facial expressions posed by ten different volunteers [60, 94]. The ten prototypical expressions of primary emotions were further manipulated by morphing software to depict expressions of mild (50%) and high (100%) intensity along the neutral-prototypical expression continuum [94]. Thus, there were ten faces with three levels of intensity, each of which was presented twice to give a total of 60 stimuli per experiment.

For example, in the ‘disgust’ experiment, participants viewed prototypically disgusted (i.e. expressions of 100% disgust), mildly disgusted (i.e. expressions of 50% disgust), and neutral expressions. Each facial stimulus was presented for 2 s. All stimuli were presented in a pseudorandomized order to avoid successive presentation of expressions of the same emotional intensity. Each stimulus type was preceded by similar numbers of each of the other two stimulus types to minimize the effect of the preceding stimulus type on neural responses to the stimulus of interest. The duration of the interstimulus interval (ISI) varied from 3 to 8 s (average 4.9 s) according to a Poisson distribution to prevent participants predicting the timing of the next stimulus presentation. During the ISI, participants viewed a fixation cross (see Figure one, Surguladze et al., for the design [60]). In subsequent analyses, the fixation cross was used as the baseline stimulus in each of the experiments. Participants were requested to decide on the sex of each face and press one of two buttons accordingly with the right thumb. The participants were familiarized with the stimuli and task procedures before scanning. In prescan testing where participants were shown the same faces as the test version but with neutral expressions only, they were all able to identify the sex of the faces correctly.

Image acquisition

Magnetic resonance (MR) images were acquired using a GE Signa 1.5 Tesla system (General Electric, Milwaukee, WI) with an operating console and software (Advanced Nuclear Magnetic Resonance, Woburn, MA) for gradient echo echoplanar imaging (EPI) at the Maudsley Hospital, London, UK. A quadrature birdcage headcoil was used for RF transmission and reception. An inversion recovery EPI dataset was acquired at 43 near-axial 3-mm-thick planes parallel to the AC-PC line: TE 73 ms, TI 180 ms, TR 16 s, in-plane voxel size 1.72 × 1.72 mm, interslice gap 0.3 mm, and matrix size: 128 × 128 pixels. This higher-resolution EPI dataset provided whole brain coverage and was later used to register the fMRI datasets acquired from each individual in standard stereotactic space. T2*-weighted images (180) depicting blood oxygenation level-dependent (BOLD) contrast were acquired at each of 16 near-axial non-contiguous 7-mm-thick planes parallel to the intercommissural (AC-PC) line: TE 40 ms, TR 2 s, in-plane voxel size 3.44 × 3.44 mm, interslice gap 0.7 mm, and matrix size: 64 × 64 pixels.

Visual stimuli were presented via a conventional PC and LCD projector system to a screen placed at the feet of the participant and projected to them via a well-positioned mirror, and overt responses were made using an MR-compatible 2-button box placed in the participant’s dominant right hand. Presentation of all stimuli and recording of all participant responses were synchronized to the imaging system. The total functional image acquisition time for each experiment was 6 min.

Neuroimaging data analysis

Individual brain activation maps

Data were analysed using a non-parametric approach with XBAM (version 4) brain image analysis software developed at the Institute of Psychiatry [95]. The images were first processed to minimize motion-related artefacts [96]. A 3D volume consisting of the average intensity at each voxel over the whole experiment was calculated and used as a template. The 3D image volume at each time point was then realigned to this template. Following realignment, data were detrended and smoothed using a Gaussian filter (FWHM 7.2 mm) to improve the signal-to-noise characteristics of the images. We did not exclude any subjects based on motion because mean motion in each of the X-Y-Z direction was under 1 mm for all of these subjects that were tested. This low level of motion artefact may be because we recruited 22q11DS and sibling participants from a sample that had successfully completed MRI structural scanning prior to this study.

Experimental responses were analysed by convolving each contrast of interest (neural responses to neutral versus baseline, emotional expressions versus baseline, respectively, and emotional expressions versus neutral) with two gamma variate functions (peak responses at 4 and 8 s, respectively). These two functions were chosen to encompass the known range of times to peak response following stimulus onset for BOLD effects. The best fit between the weighted sum of these convolutions and the time series at each voxel was computed using Friman’s constrained BOLD effect model [97]. Following the computation of the model fit, a goodness-of-fit statistic was computed. This consisted of the ratio of the sum of squares of deviations from the mean image intensity (over the whole time series) due to the model to the sum of squares of deviations due to the residual sum of squares (SSQ) ratio. Following the computation of the observed SSQ ratio at each voxel, the data were permuted by the wavelet-based method described in [98]. This allowed the data-driven calculation of the null distribution of SSQ ratios under the assumption of a no experimentally determined response. Using this distribution, it is possible to calculate the critical value of the SSQ ratio needed to threshold the maps at any desired type I error rate. The detection of activated voxels was then extended from the voxel-to-cluster level using the method described in detail by [99].

Group brain activation maps

The observed and permuted SSQ ratio maps for each individual were transformed into standard space [100] using a two-stage warping procedure described in detail in [95]. Group activation maps were then computed by determining the median SSQ ratio at each voxel (over all individuals) in the observed and permuted data maps (medians are used to minimize outlier effects). In the two-level clustering procedure (described in detail in Bullmore et al, 1999 [99]), the first (voxel-wise) thresholding was carried out at an uncorrected p value of 0.05 to give the maximum allowable sensitivity. In order to eliminate the resulting false positive activations, a second cluster-level thresholding step was carried out and the threshold of this second step was adjusted to give an expectation of less than one false positive cluster over the whole brain. Thus, the computation of a standardized measure of SSQ ratio at the individual level, followed by analysis of the median SSQ ratio maps over all individuals, treats intra- and interparticipant variations in effect separately. This constitutes a mixed-effect approach that allows for inferences from these results to be made about the larger population—in other words, people with 22q11DS as a whole (assuming a representative sample).

Within-group linear trend analysis

Voxel- and cluster-wise within-group differences in BOLD signal change to the two different types of facial expression versus the baseline were examined using repeated measures analysis of variance (ANOVA), with intensity (neutral, 50% intensity, 100% intensity) as the within-participant variable. Each ANOVA was constrained to detect brain regions demonstrating linear trends of activation—in other words, areas where activity changes in a stepwise way across levels of emotion intensity regardless of direction (i.e. both positive and negative trends).

Between-group and group-by-intensity interaction analysis

A 3 × 2 repeated measures ANOVA was undertaken to determine voxel- and cluster-wise between-group differences in BOLD signal to the two different types of facial expression versus baseline, with intensity (neutral, 50% intensity, 100% intensity) as the within-participant variable for each emotion type and group (22q11DS, controls) as the between-group variable. Group × intensity interactions refer to brain regions showing differences in the effect of changes in emotion intensity on neural response in children with 22q11DS relative to healthy controls. The main effects of group refer to the differences between children with 22q11DS relative to controls in the neural response to all emotion intensities (neutral, mild, and intense) considered together.

Post hoc analysis

Further tests of between-group differences in neural response to each of the three different emotion expression-baseline contrasts for each separate emotion were examined with post hoc ANOVAs. In addition, neural responses to neutral expressions from both experiments were combined to increase experimental power.

Correlations between brain activity during facial emotion processing and social behaviour

We also conducted an exploratory correlation analysis, within the 22q11DS group, of measures of social behaviour and brain activity in regions where healthy controls activated significantly more than the 22q11DS group (i.e. employing a ‘mask’ derived from brain regions showing a main effect of group on neural responses to facial expressions for fearful and disgusted expressions respectively.) Since not all the guardians agreed to complete these questionnaires, we could only include data from 11 of the 14 children with 22q11DS for this analysis. The aim was to determine what, if any, functional abnormalities might be associated with social difficulties in people with 22q11DS as measured by SDQ total difficulties score (abnormal score ≥17).

Results

Demographic details and behavioural results

There were no significant between-group differences in age (t(26) = .07, p > .05), response accuracy (Fear: t(26) = 1.48, p > .05; Disgust: t(26) = .52, p > .05), or reaction times (Fear: t(26) = 1.12, p > .05; Disgust: t(26) = .84, p > .05). However, as noted above, as expected, the healthy controls had a significantly higher FSIQ (t(26) = 10.4, p < .001) (see Table 1).

Face versus fixation cross contrasts

Results of contrasts of neutral faces versus fixation cross, and prototypic (100% intensity) facial emotions versus fixation cross for each group, are in the Additional file 1. In summary, these contrasts revealed fusiform and extrastriate activations in both children with 22q11DS and controls, along with activation in other brain regions involved in face perception (e.g. superior temporal gyri, insula, anterior cingulate gyri, and medial frontal gyri).

Within group linear trend analysis

Table 2 shows results of repeated measures ANOVA of neural responses to facial expressions of neutral, mild, and intense emotion for fearful and disgusted expressions, respectively. Positive linear trends (i.e. increased levels of activation as the intensity of the facial expression increased) were found for fearful expressions in both groups and for disgusted expressions in the 22q11DS group (Table 2). Negative linear trends of activation (i.e. decreased levels of activation as the intensity of the facial expression increased) to disgusted expressions were present in the controls (Table 2). In summary, we found significant positive trends of activation in fusiform-extrastriate regions and cerebellum to increasing intensities of fear in both groups, and positive trends in similar areas to increasing intensities of facial disgust in children and adolescents with 22q11DS.

Table 2

The effect of emotional intensity

		22q11DS					Controls
Brain region	BA	X	Y	Z	Size	p value	X	Y	Z	Size	p value
FEAR
Middle occipital gyrus
Right	18	29	-78	-7	8
Lingual gyrus
Right	18	18	-78	-7	5
Precentral gyrus
Left	4						-36	-22	48	76	0.007657
Postcentral gyrus
Left	2						-47	-19	31	10
Inferior parietal lobule
Left	40						-40	-30	42	16
Cerebellum
Left							-40	-63	-29	83	0.006032
Right		29	-78	-13	62	0.00486	32	-63	-29	83	0.007889
DISGUST
Inf-post temporal lobe
Right	37	36	-56	-2	96	0.008705
Middle occipital gyrus
Right	18	32	-78	4	17
Inferior occipital gyrus
Right	19	32	-78	9	7
Fusiform gyrus
Right	37	36	-56	-7	37
Middle temporal gyrus
Right	21	54	-37	-2	6
Lingual gyrus
Right	18						14	-85	-7	106	0.004004
Medial frontal gyrus
Left	6						-4	4	48	66	0.005116
Cingulate gyrus
Left	24						-4	4	42	15
Cerebellum
Right		29	-63	-13	9		25	-70	-13	9

Brain regions showing significant trends of activation to increasing intensity of emotion (neutral, mild, intense) for fearful and disgusted expressions. Both groups showed positive trend (i.e. increasing activation with the increasing emotional intensity) for ‘fear’. For ‘disgust’, the 22q11DS group showed positive trend whereas the controls showed negative trends (i.e. decreasing activation with increasing emotional intensity—shown in italics). Statistical thresholds adjusted so as to get less than one false positive cluster per map.

Between-group and group-by-intensity interaction analysis

The main effects of group on neural response to expression (neutral, mild, and intense emotion) and interactions between group (controls, 22q11DS) and expression intensity (neutral, mild, and intense emotion) for fearful and disgusted expressions, respectively, are shown in Table 3. Figures 1 and 2 show brain activation maps of the main effects of group. Briefly, we found that, compared to healthy controls, children with 22q11DS showed reduced activations of the extrastriate cortices (including FG), postcentral gyrus, precentral gyrus, and cerebellum in response to the expressions of fear and disgust (i.e. main effects of group). Tests of interactions showed that there were significant group × intensity interactions in the left precentral gyrus for fear, whereas the significant interactions for disgust were found in the left precentral gyrus, the right cingulate gyrus, and the left cerebellum. This result indicates that neural ‘hyporesponsiveness’ in children and adolescents with 22q11DS varies depending on emotion type. Furthermore, the pattern of the results remained unchanged even when we repeated the analyses using FSIQ as a covariate to see if any differences observed might reflect the differences in FSIQ between the groups.

Table 3

The main effect of group and group × intensity interaction

		Fear					Disgust
Brain region	BA	X	Y	Z	Size	p value	X	Y	Z	Size	p value
Controls > 22q11DS
Fusiform gyrus
Left	19	-36	-74	-13	27		-40	-70	-18	49
Right	19						29	-81	-13	119	0.003945
Inferior occipital gyrus
Left	19	-36	-78	-7	5
Insula
Left	13						-29	-30	26	10
Superior frontal gyrus
Right	6	4	11	48	164	0.003543
Postcentral gyrus
Left	3	-32	-30	48	37		-29	-30	48	180	0.001517
Precentral gyrus
Left	4	-36	-19	48	136	0.000273	-36	-19	53	21
Transverse temporal gyrus
Left	41						-47	-22	9	5
Cingulate gyrus
Right	32	0	11	37	33
Cerebellum
Left		-36	-79	-18	186	0.000273	-40	-44	-24	173	0.000305
Right							25	-74	-24	40
GROUP × INTENSITY
Fusiform gyrus
Left	19						-32	-74	-18	22
Precentral gyrus
Left	4	-32	-22	53	50	0.005263	-29	-22	53	92	0.00246
Medial frontal gyrus
Right	6						0	-11	53	7
Superior frontal gyrus
Right	6						0	4	48	23
Cingulate gyrus
Right	24						0	4	42	63	0.006812
Postcentral gyrus
Left	3	-32	-33	48	21		-32	-22	42	27
Inferior parietal lobule
Left	40						-47	-30	31	5
Cerebellum
Left							-40	-70	-24	99	0.002271

Brain regions showing main effects of group and group × intensity level interactions for each emotion experiment. Talairach coordinates in italic print indicate the most activated voxel within a cluster. Other Talairach coordinates represent other active areas in clusters (derived from decomposition of each cluster into contiguous slices, 5.72-mm diameter in the z dimension). Statistical thresholds adjusted so as to get less than one false positive cluster per map.

Post hoc analysis

To further clarify these group × intensity interactions and the main effects of group, separate post hoc two-way ANOVA comparisons of neutral, mild, and intense emotion for the fear and disgust experiments are shown in Tables 4 and 5, respectively. In brief, controls showed significantly higher activations than people with 22q11DS in response to fearful emotion in the postcentral gyrus, the left superomedial frontal gyrus, and the bilateral cerebellum across emotional intensities. For disgusted facial emotion, controls activated significantly more than the 22q11DS group in the left fusiform gyrus, left postcentral gyrus, and the bilateral cerebellum. We found that there were no brain regions where people with 22q11DS activated more than controls in response to fearful, disgusted, or neutral facial expressions.

Table 4

Post hoc analyses on group × intensity interaction for fear

		Intense				Mild				Neutral
Brain region	BA	X	Y	Z	Size	X	Y	Z	Size	X	Y	Z	Size
Control > 22q11DS
Fusiform gyrus
Left	19					-29	-81	-13	24	-36	-70	-13	26
Right	19									33	-78	-13	64
Thalamus
Left										-7	-15	15	7
Paracentral lobule
Left	31									0	-11	48	13
Precentral gyrus
Left	4	-32	-22	53	23	-36	-22	53	22
Postcentral gyrus
Left	3	-33	-22	48	135	-33	-22	48	174	-40	-26	48	80
Medial frontal gyrus
Left	32	7	11	42	23	0	11	42	128
Superior frontal gyrus
Left	6	7	11	48	99
Right	6					4	11	48	31
Cingulate gyrus
Left	24	-7	7	26	7					0	15	37	95
Right	32	11	11	37	22	11	11	37	27	0	-4	26	16
Cerebellum
Left		-33	-70	-24	135	-33	-67	-29	120	-36	-70	-18	163
Right		36	-70	-24	84

Post hoc between-group two-way ANOVA comparisons of neural responses to intense, mild, and neutral expressions, respectively, for fearful emotion experiment. Talairach coordinates in italic print indicate the most activated voxel within a 3D cluster. Other Talairach coordinates represent other active areas in clusters (derived from decomposition of each cluster into contiguous slices, 5.72-mm diameter in the z dimension). Statistical thresholds adjusted so as to get less than one false positive cluster per map.

Table 5

Post hoc analyses on group × intensity interaction for disgust

		Intense				Mild				Neutral
Brain region	BA	X	Y	Z	Size	X	Y	Z	Size	X	Y	Z	Size
Control > 22q11DS
Fusiform gyrus
Left	19	-40	-70	-13	24					-36	-67	-13	23
Right										32	-78	-13	19
Inferior parietal lobule
Left	40					-40	-37	37	32
Insula
Left	13	-29	-30	26	8					-43	-30	20	8
Precentral gyrus
Left	4	-36	-19	53	6	-29	-26	53	18	-36	-15	53	14
Postcentral gyrus
Left	3	-29	-30	48	72	-29	-30	48	162	-33	-22	42	125
Middle occipital gyrus
Left	18	-22	-85	-7	5
Medial frontal gyrus
Left	32					0	7	42	72
Cingulate gyrus
Right	24					7	7	37	19
Cerebellum
Left		36	-48	-24	78	-40	-70	-18	85	-36	-67	-18	173
Right		-43	-59	-29	148	25	-81	-24	78	33	-78	-18	137

Post hoc between-group two-way ANOVA comparisons of neural responses to intense, mild, and neutral expressions, respectively, for disgusted emotion experiment. Talairach coordinates in italic print indicate the most activated voxel within a cluster. Other Talairach coordinates represent other active areas in clusters (derived from decomposition of each cluster into contiguous slices, 5.72-mm diameter in the z dimension). Statistical thresholds adjusted so as to get less than one false positive cluster per map.

Correlation with behavioural measures

Eleven children with 22q11DS and nine siblings provided the parent’s version of the SDQ. The siblings scored well under the cut-off scores for all of the subscales, while children with 22q11DS scored in the borderline—abnormal range for the ‘Emotional Symptoms’ and ‘Peer Problems’ scores which are related to social behaviour (see Table 1). These two subscales were the only ones that yielded significant group difference. We used the ‘Total Difficulties Score’ for exploratory correlation analysis which is generated by summing the subscale scores including these two because it is a well-established measure for screening for behavioural, emotional, and social difficulties among children both at home and school [84, 93, 101, 102]. In children with 22q11DS, we found a significant correlation between decreasing brain activations as the SDQ Total Difficulties Score increased, to fearful expressions in the left precentral gyrus (BA 4, r = 0.453), and to disgusted expressions in the left fusiform gyrus (BA 19, r = 0.447), right lingual gyrus (BA 18) (Figure 3), and bilateral cerebellum (r = 0.613).

Discussion

We carried out a cross-sectional event-related fMRI study in children and adolescents with 22q11DS and healthy controls. We examined neural responses to increasing intensities of two primary emotions—fear and disgust. Our main findings were that a) fusiform-extrastriate cortices and other components of ‘face responsive’ networks are engaged by fearful, disgusted, and neutral expressions both in young individuals with 22q11DS and in healthy controls; b) children with 22q11DS, like healthy controls, show increased activity in visual cortices and other brain regions with increasing intensity of fearful expressions; c) but, compared to controls, children with 22q11DS display a different pattern of modulation (i.e. increased activation) of right extrastriate cortical activity with increasing intensity of disgusted expressions.; and d) despite these between-group differences in the modulation of brain activity by emotion type and intensity, there were no brain regions where young people with 22q11DS showed greater activation to facial expressions of any type or intensity compared to typically developing controls. This is in line with previous findings of reduced FG response to faces in young people with 22q11DS [78] and is, in part, consistent with prior findings of frontal hyporesponsiveness to mixed facial expressions of emotion in adults with 22q11DS [75]. However, while the latter study reported higher activation of posterior regions in adults with 22q11DS compared to controls [75], as noted, we found no brain regions where the neural activations were higher in the 22q11DS group.

In addition, between-group differences in regional brain activation to facial expressions appear to be directly related to difficulties in social behaviour. For example, we found a negative correlation between brain activity and SDQ total difficulties score (a measure of difficulties in behaviour, emotions, and relationships) in the left precentral gyrus (BA 4) (for fear) and in the left FG (BA 19), right lingual gyrus (BA 18), and bilateral cerebellum (for disgust). Consequently, reduced responsiveness of these ‘face responsive’ regions to facial expressions of fear and disgust may contribute to the difficulties in social behaviour in people with 22q11DS. However, given the small sample size in the current study, further studies with larger samples will be required to validate this finding.

Similar findings of reduced activations of fusiform-extrastriate cortices to emotional and neutral facial expressions have been reported in an event-related fMRI study of people with ASD compared to healthy controls, using a similar incidental facial emotion processing task [103]. It has been suggested that fusiform-extrastriate hypoactivation in people with ASD may result from a failure of feedback modulation from limbic structures [63]. Similarly, fusiform-extrastriate hypoactivation in young people with 22q11DS may also relate to amygdala and other limbic abnormalities. For example, there is evidence of a lack of amygdala modulation by fearful expressions in young people with 22q11DS [78], while anomalies in limbic structures, along with other regions, have been reported from studies in 22q11DS [87, 104, 105]. The non-uniform pattern of between-group differences across emotion types and intensities in our study suggests that reduced feedback modulation from the amygdala may not be the sole explanation for our findings in 22q11DS. An alternative possibility is that limbic modulation of visual cortices involves the amygdala acting in concert with other limbic structures depending on the type and intensity of emotion. This hypothesis would be consistent both with the view that the amygdala is involved in conferring salience on a wide range of social and non-social stimuli [106] and with studies that reported differential activation of limbic structures in response to distinct facial emotion types—such as the amygdala for fear [107] and insula for disgust [108]. Hence, the between-group differences we found between people with 22q11DS and controls in visual cortical activation may reflect differences in modulatory input from limbic and other brain regions that vary with emotion type and intensity.

Compared to controls, the 22q11DS group also showed reduced activation in the anterior cingulate gyrus (BA 32/24). The dorsal region of the anterior cingulate cortex (BA 24/32) has been implicated in executive function, such as selective attention and planning, as well as in the regulation of affective states [46]. Hence, hypoactivation of the anterior cingulate gyrus in response to a range of expression types and intensities may relate to difficulties in regulating affective responses to emotional stimuli and in integrating affective responses to expressions with the executive control of behaviour.

Reduced brain activation in the 22q11DS group was also found in the superomedial prefrontal cortex (BA 6). Activation of this area in response to facial emotion stimuli has been reported in neuroimaging studies employing similar facial emotion processing tasks [60, 103]. In addition, BA 6 is also active during the production of empathetic facial expressions [109‐111]. Relative hypoactivation of superomedial prefrontal regions in 22q11DS may therefore be related both to the failure to recognize and/or affectively respond to the facial displays of others and to the lack of facial expression reported in people with 22q11DS [17, 30].

Activations in the cerebellum during facial emotion and other affective processing tasks have been reported by prior human studies [57, 64, 65, 67, 103, 112‐114]. While no consistent differential brain activations in facial emotion processing tasks have been found [57], it has been suggested that the cerebellum may contribute both to empathic processing [115, 116] and to the generation of affective states [104, 117]. Thus, the lower cerebellar activation observed in children with 22q11DS as compared to the healthy controls may result in diminished affective responsiveness to facial displays of expression. Cerebellar hypoactivation to facial expressions may also be associated with problems in social behaviour. For example, we found a significant negative correlation between adaptive social behaviour (as measured by the SDQ total difficulty scores which measure difficulties in behaviour, emotions, and peer relationships) and the left cerebellar activation to disgust in people with 22q11DS [103].

One possible explanation for differences in modulation of social brain regions by different types and intensity of facial expression may be variation in dopamine metabolism—for example, associated with variation in catechol-O-methyl transferase (COMT), a methylation enzyme that metabolizes catecholamines (including dopamine) [118]. In other words, dopamine levels in social brain regions could be abnormal in people with 22q11DS who have haploinsufficiency in COMT [119‐122]. We will address this issue in future larger studies.

Alternatively, differences in function of social brain regions may be explained by differences in brain anatomy. We have previously reported a relationship between differences in regional brain volume and social behaviour in young people with 22q11DS [87]. Thus, larger studies are required to investigate the relationship between differences in anatomy and function (if any).

There are several limitations in our study. For example, the sample size was relatively small, and the controls scored significantly higher on tests of intellectual functioning compared to people with 22q11DS (FSIQ: 114 vs. 66). Hence, it could be suggested that our results may be explained by differences in intellectual ability, and it might therefore have been better to have included an IQ-matched non-deleted control group who were also matched on social and environmental factors. However, we compared people with 22q11DS to healthy controls (including siblings of the 22q11DS participants, when available) because we wanted to find out how brain activation in people with 22q11DS differs from those with optimal brain development. Also, both groups showed activations in brain regions reported by others to be specifically implicated in facial emotion processing [59, 60], and the pattern of the results remained unchanged even when we analysed the group differences using FSIQ as a covariate. Furthermore, unrelated controls with intellectual disabilities would most likely have comprised a heterogeneous population with a large variety of genetic and environmental/social differences. Hence, where possible, we used sibling controls to account, as best we could, for environmental and social differences. Thus, the significantly higher activations in the healthy control group probably cannot be solely attributed to environmental and/or socio-economic factors. Another point regarding the use of siblings as controls is that they may not represent typically developing healthy children. For example, imaging studies on individuals with autism have shown that non-autistic siblings of individuals with autism showed patterns of brain activation that are similar to those with autism [123] or different from those with autism and non-sibling controls [124]. Future research could therefore include sibling and non-sibling controls to address the issue of whether there are any differences in brain activation between sibling and non-sibling controls in the case of 22q11DS.

We did not acquire behavioural data about accuracy of facial emotion recognition because we employed incidental (gender discrimination) rather than explicit (emotion recognition) task. An incidental emotion processing task was chosen because emotion appraisal in routine social interaction often occurs automatically (without conscious deliberation) [125]. Therefore, we believe our paradigm to be more appropriate for investigating between-group differences in brain systems that are routinely engaged in social interaction.

We found widespread limbic and subcortical activations in our face versus fixation cross contrasts for both disgusted and fearful emotion across different levels of intensity (see Additional file 1) and between-group differences in activation of the insula to disgusted expressions (see the “Results” section). In contrast, we failed to find activation of the amygdala in any of our contrasts. However, not all previous studies of facial fear perception in healthy participants have demonstrated amygdala activation [126]. Similarly, the previous study on facial emotion processing in adults with 22q11DS reported higher insula activation in the control group, but they found no between-group difference in amygdala activations [75]. These results may not necessarily reflect absence of amygdala activation but, rather, limitations of MRI acquisition and the relatively small sample size in these studies. However, despite the relatively small sample size (n = 14), our results demonstrate that we had sufficient statistical power to detect differences in activation. Also, the areas we report are likely to remain differentially active even if additional active areas are revealed by increased sample size and optimized MRI acquisition parameters. Moreover, the results we report are likely to represent true activations because of the use of a conservative analysis and thresholding method to reduce the risk of Type 1 errors (see the “Methods” section).

Conclusions

Both children and adolescents with 22q11DS and healthy controls demonstrated activation in ‘face responsive’ regions, including fusiform-extrastriate cortices, anterior cingulate cortex (BA 24), and superomedial prefrontal cortex (BA 6) in response to facial expressions of emotion (fear and disgust). However, the patterns of these activations vary depending on emotion type and intensity and differ between groups. Furthermore, compared to healthy controls, children with 22q11DS consistently showed significantly lower brain activations for both emotion types, across intensities, in these regions. Activity in some of these regions (e.g. left precentral gyrus (BA 4) to fear, and left FG (BA 19) and right lingual gyrus (BA 18) to disgust) also negatively correlated with the extent of social difficulties. Hypoactivation in these regions may therefore partly explain the social impairments of children with 22q11DS. However, further studies are required to determine the relationship between these findings and the social impairments of people with 22q11DS and how these abnormalities arise and change with age.

Authors’ information

Rayna Azuma and Quinton Deeley are joint first authors.

Acknowledgements

The authors would like to thank all the young people with and without 22q11DS who took part in the study, the 22q11 (UK) Support Group for their help and support in recruitment, and the radiographers in the Department of Neuroimaging at the Maudsley Hospital for their expertise and work in acquiring the scans.

Funding

This research was funded by The Healthcare Trust, The Wellcome Trust, the Mortimer D Sackler Foundation, and the South London and Maudsley NHS Foundation Trust. This work was also supported by the NIHR Biomedical Research Centre for Mental Health at King’s College London, Institute of Psychiatry and by MEXT. KIBANKEISEI (2010).

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Electronic supplementary material

Goldenberg PC, Calkins ME, Richard J, McDonald-McGinn D, Zackai E, Mitra N, Emanuel B, Devoto M, Borgmann-Winter K, Kohler C, Conroy CG, Gur RC, Gur RE: Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. Am J Med Genet B Neuropsychiatr Genet 2012, 1:87–93.CrossRef

Scambler PJ, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R, Wilson DI, Goodship JA, Cross IE, Burn J: Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992, 9:339. 1138–1139

Karayiorgou M, Simon TJ, Gogos JA: 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 2010, 11:402–416. 10.1038/nrn2841PubMedCentralPubMedCrossRef

Hoogendoorn MLC, Vorstman JAS, Jalali GR, Selten J-P, Sinke RJ, Emanuel BS, Kahn RS: Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia. Schizophr Res 2008, 98:84–88.PubMedCentralPubMedCrossRef

Oskarsdottir S, Vujic M, Fasth A: Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004, 89:148–151. 10.1136/adc.2003.026880PubMedCentralPubMedCrossRef

Tezenas Du Montcel S, Mendizabai H, Ayme S, Levy A, Philip N: Prevalence of 22q11 microdeletion. J Med Genet 1996, 33:719.PubMedCentralPubMedCrossRef

Gothelf D, Frisch A, Munitz H, Rockah R, Laufer N, Mozes T, Hermesh H, Weizman A, Frydman M: Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res 1999, 35:105–112. 10.1016/S0920-9964(98)00114-5PubMedCrossRef

Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D: A new syndrome involving cleft palate, cardiac abnormalitiesm typical facies and learning disabilities: velo-cardio-facial syndrome. Cleft Palate 1978, 15:15–62.

Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999, 56:940–945. 10.1001/archpsyc.56.10.940PubMedCrossRef

10.

Papolos DF, Faedda GL, Veit S, Goldberg R, Morrow B, Kucherlapati R, Shprintzen RJ: Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatr 1996, 153:1541–1547.PubMedCrossRef

11.

Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D, Kucheriapati R: Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nervous Mental Dis 1994, 1994:182(8).

12.

Tang SX, Yi JJ, Moore TM, Calkins ME, Kohler CG, Whinna DA, Souders MC, Zackai EH, McDonald-McGinn DM, Emanuel BS, Bilker WB, Gur RC, Gur RE: Subthreshold psychotic symptoms in 22q11.2 deletion syndrome. J Am Acad Child Adolesc Psychiatry 2014, 53:991–1000. e1002 10.1016/j.jaac.2014.05.009PubMedCrossRef

13.

Jonas RK, Montojo CA, Bearden CE, Tang SX, Yi JJ, Moore TM, Calkins ME, Kohler CG, Whinna DA, Souders MC, Zackai EH, McDonald-McGinn DM, Emanuel BS, Bilker WB, Gur RC, Gur RE: The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan: subthreshold psychotic symptoms in 22q11.2 deletion syndrome. Biol Psychiatry 2014, 75:351–360. 10.1016/j.biopsych.2013.07.019PubMedCentralPubMedCrossRef

14.

Goldberg R, Motzkin B, Marion R, Scambler PJ, Shprintzen RJ, Goldberg R, Motzkin B, Marion R, Scambler PJ, Shprintzen RJ: Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet 1993, 45:313–319. 10.1002/ajmg.1320450307PubMedCrossRef

15.

Gothelf D, Schaer M, Eliez S: Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev 2008, 14:59–68. 10.1002/ddrr.9PubMedCrossRef

16.

Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C: Neuropsychiatric disorders in the 22q11 deletion syndrome. Genetics Med 2001, 3:79–84. 10.1097/00125817-200101000-00017CrossRef

17.

Swillen A, Devriendt K, Legius E, Eyskens B, Dumoulin M, Gewillig M, Fryns JP: Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 1997, 34:453–458. 10.1136/jmg.34.6.453PubMedCentralPubMedCrossRef

18.

Campbell LE, Azuma R, Ambery F, Stevens A, Smith A, Morris RG, Murphy DGM, Murphy KC: Executive functions and memory abilities in children with 22q11.2 deletion syndrome. Aust N Z J Psychiatry 2010, 44:364–371. 10.3109/00048670903489882PubMedCrossRef

19.

Campbell LE, Stevens A, Daly E, Toal F, Azuma R, Karmiloff-Smith A, Murphy DGM, Murphy KC: A comparative study of cognition and brain anatomy between two neurodevelopmental disorders: 22q11.2 deletion syndrome and Williams syndrome. Neuropsychologia 2009, 47:1034–1044. 10.1016/j.neuropsychologia.2008.10.029PubMedCrossRef

20.

Henry JC, van Amelsvoort T, Morris RG, Owen MJ, Murphy DG, Murphy KC: An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS). Neuropsychologia 2002, 40:471–478. 10.1016/S0028-3932(01)00136-1PubMedCrossRef

21.

Moss EM, Batshaw ML, Solot CB, Gerdes M, McDonald-McGinn DM, Driscoll DA, Emanuel BS, Zackai EH, Wang PP, Moss EM, Batshaw ML, Solot CB, Gerdes M, McDonald-McGinn DM, Driscoll DA, Emanuel BS, Zackai EH, Wang PP: Psychoeducational profile of the 22q11.2 microdeletion: a complex pattern.[see comment]. J Pediatr 1999, 134:193–198. 10.1016/S0022-3476(99)70415-4PubMedCrossRef

22.

Swillen A, Vogels A, Devriendt K, Fryns JP: Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet 2000, 97:128–135. 10.1002/1096-8628(200022)97:2<128::AID-AJMG4>3.0.CO;2-ZPubMedCrossRef

23.

van Amelsvoort T, Henry J, Morris R, Owen M, Linszen D, Murphy K, Murphy D: Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr Res 2004, 70:223–232. 10.1016/j.schres.2003.10.004PubMedCrossRef

24.

Green T, Gothelf D, Glaser B, Debbane M, Frisch A, Kotler M, Weizman A, Eliez S: Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolescent Psychiatry 2009, 48:1060–1068. 10.1097/CHI.0b013e3181b76683CrossRef

25.

Drew LJ, Crabtree GW, Markx S, Stark KL, Chaverneff F, Xu B, Mukai J, Fenelon K, Hsu P-K, Gogos JA, Karayiorgou M: The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int J Dev Neurosci 2011, 29:259–281. 10.1016/j.ijdevneu.2010.09.007PubMedCentralPubMedCrossRef

26.

Azuma R, Daly EM, Campbell LE, Stevens AF, Deeley Q, Giampietro V, Brammer MJ, Glaser B, Ambery FZ, Morris RG, Williams SCR, Owen MJ, Murphy DGM, Murphy KC: Visuospatial working memory in children and adolescents with 22q11.2 deletion syndrome; an fMRI study. J Neurodev Disord 2009, 1:46–60. 10.1007/s11689-009-9008-9PubMedCentralPubMedCrossRef

27.

Swillen A, Devriendt K, Legius E, Prinzie P, Vogels A, Ghesquiere P, Fryns JP: The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns 1999, 10:79–88.PubMed

28.

Swillen A, Vandeputte L, Cracco J, Maes B, Ghesquiere P, Devriendt K, Fryns JP: Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol 1999, 5:230–241. 10.1076/0929-7049(199912)05:04;1-R;FT230PubMedCrossRef

29.

Kiley-Brabeck K, Sobin C: Social skills and executive function deficits in children with the 22q11 Deletion Syndrome. Appl Neuropsychol 2006, 13:258–268. 10.1207/s15324826an1304_7PubMedCentralPubMedCrossRef

30.

Golding-Kushner KJ, Weller G, Shprintzen RJ: Velo-cardio-facial syndrome: language and psychological profiles. J Craniofacial Genetics Dev Biol 1985, 5:259–266.

31.

Schonherz Y, Davidov M, Knafo A, Zilkha H, Shoval G, Zalsman G, Frisch A, Weizman A, Gothelf D: Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome. J Neurodev Disord 2014, 6:3. 10.1186/1866-1955-6-3PubMedCentralPubMedCrossRef

32.

Niklasson L, Gillberg C: The neuropsychology of 22q11 deletion syndrome: a neuropsychiatric study of 100 individuals. Res Dev Disabil 2010, 31:185–194. 10.1016/j.ridd.2009.09.001PubMedCrossRef

33.

Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C: Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects. Dev Med Child Neurol 2002, 44:44–50. 10.1017/S0012162201001645PubMedCrossRef

34.

Baker K, Vorstman JA: Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome? Curr Opin Neurol 2012, 25:131–137. 10.1097/WCO.0b013e328352dd58PubMedCrossRef

35.

Fine SE, Weissman A, Gerdes M, Pinto-Martin J, Zackai EH, McDonald-McGinn DM, Emanuel BS: Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disorders 2005, 35:461–470. 10.1007/s10803-005-5036-9CrossRef

36.

Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T: Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006, 368:210–215. 10.1016/S0140-6736(06)69041-7PubMedCrossRef

37.

Charles JM, Carpenter LA, Jenner W, Nicholas JS: Recent advances in autism spectrum disorders. Int J Psychiatry Med 2008, 38:133–140. 10.2190/PM.38.2.aPubMedCrossRef

38.

Fombonne E: The epidemiology of autism: a review. Psychol Med 1999, 29:769–786. 10.1017/S0033291799008508PubMedCrossRef

39.

Fombonne E: Epidemiological trends in rates of autism. Mol Psychiatry 2002,7(Suppl 2):S4-S6.PubMedCrossRef

40.

Fombonne E: Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Dis 2003, 33:365–382. 10.1023/A:1025054610557CrossRef

41.

Fombonne E: Epidemiology of autistic disorder and other pervasive developmental disorders.[see comment]. J Clin Psychiatry 2005,66(Suppl 10):3–8.PubMed

42.

Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, Reynolds AM, Rice CE, Schendel D, Windham GC: The epidemiology of autism spectrum disorders. Annu Rev Public Health 2007, 28:235–258. 10.1146/annurev.publhealth.28.021406.144007PubMedCrossRef

43.

Nicholas JS, Charles JM, Carpenter LA, King LB, Jenner W, Spratt EG: Prevalence and characteristics of children with autism-spectrum disorders. Ann Epidemiol 2008, 18:130–136. 10.1016/j.annepidem.2007.10.013PubMedCrossRef

44.

Schreiner MJ, Karlsgodt KH, Uddin LQ, Chow C, Congdon E, Jalbrzikowski M, Bearden CE: Default mode network connectivity and reciprocal social behavior in 22q11.2 deletion syndrome. Soc Cogn Affect Neurosci 2014, 9:1261–1267. 10.1093/scan/nst114PubMedCrossRef

45.

Phillips ML, Drevets WC, Rauch SL, Lane R: Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 2003, 54:515–528. 10.1016/S0006-3223(03)00171-9PubMedCrossRef

46.

Phillips ML, Drevets WC, Rauch SL, Lane R: Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry 2003, 54:504–514. 10.1016/S0006-3223(03)00168-9PubMedCrossRef

47.

APA: Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington: American Psychiatric Association; 2013.

48.

Schultz RT: Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int J Dev Neurosci 2005, 23:125–141. 10.1016/j.ijdevneu.2004.12.012PubMedCrossRef

49.

WHO: The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines 1992; Diagnostic Criteria for Research. Geneva: WHO; 1993.

50.

Lajiness-O’Neill RR, Beaulieu I, Titus JB, Asamoah A, Bigler ED, Bawle EV, Pollack R: Memory and learning in children with 22q11.2 deletion syndrome: evidence for ventral and dorsal stream disruption? Child Neuropsychol 2005, 11:55–71. 10.1080/09297040590911202PubMedCrossRef

51.

Campbell L, McCabe K, Leadbeater K, Schall U, Loughland C, Rich D: Visual scanning of faces in 22q11.2 deletion syndrome: attention to the mouth or the eyes? Psychiatry Res 2010, 177:211–215. 10.1016/j.psychres.2009.06.007PubMedCrossRef

52.

Glaser B, Debbané M, Ottet M-C, Vuilleumier P, Zesiger P, Antonarakis SE, Eliez S: Eye gaze during face processing in children and adolescents with 22q11.2 deletion syndrome. J Am Acad Child Adolesc Psychiatry 2010, 49:665–674.PubMed

53.

Jalbrzikowski M, Carter C, Senturk D, Chow C, Hopkins JM, Green MF, Galván A, Cannon TD, Bearden CE: Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis? Schizophr Res 2012, 142:99–107. 10.1016/j.schres.2012.10.007PubMedCentralPubMedCrossRef

54.

McCabe K, Rich D, Loughland CM, Schall U, Campbell LE: Visual scanpath abnormalities in 22q11.2 deletion syndrome: is this a face specific deficit? Psychiatry Res 2011, 189:292–298. 10.1016/j.psychres.2011.06.012PubMedCrossRef

55.

McCabe KL, Melville JL, Rich D, Strutt PA, Cooper G, Loughland CM, Schall U, Campbell LE: Divergent patterns of social cognition performance in autism and 22q11.2 deletion syndrome (22q11DS). J Autism Dev Disord 2013, 43:1926–1934. 10.1007/s10803-012-1742-2PubMedCrossRef

56.

Campbell LE, Stevens AF, McCabe K, Cruickshank L, Morris RG, Murphy DGM, Murphy KC: Is theory of mind related to social dysfunction and emotional problems in 22q11.2 deletion syndrome (velo-cardio-facial syndrome)? J Neurodev Disord 2011, 3:152–161. 10.1007/s11689-011-9082-7PubMedCentralPubMedCrossRef

57.

Fusar-Poli P, Placentino A, Carletti F, Landi P, Allen P, Surguladze S, Benedetti F, Abbamonte M, Gasparotti R, Barale F, Perez J, McGuire P, Politi P: Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci 2009, 34:418–432.PubMedCentralPubMed

58.

Sabatinelli D, Fortune EE, Li Q, Siddiqui A, Krafft C, Oliver WT, Beck S, Jeffries J: Emotional perception: meta-analyses of face and natural scene processing. Neuroimage 2011, 54:2524–2533. 10.1016/j.neuroimage.2010.10.011PubMedCrossRef

59.

Haxby JV, Hoffman EA, Gobbini MI: Human neural systems for face recognition and social communication. Biol Psychiatry 2002, 51:59–67. 10.1016/S0006-3223(01)01330-0PubMedCrossRef

60.

Surguladze SA, Brammer MJ, Young AW, Andrew C, Travis MJ, Williams SCR, Phillips ML: A preferential increase in the extrastriate response to signals of danger. Neuroimage 2003, 19:1317–1328. 10.1016/S1053-8119(03)00085-5PubMedCrossRef

61.

Frith C: What do imaging studies tell us about the neural basis of autism? Novartis Found Symp 2003, 251:149–166. discussion 166–176PubMedCrossRef

62.

Morris JS, Friston KJ, Buchel C, Frith CD, Young AW, Calder AJ, Dolan RJ: A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain 1998, 121:47–57. 10.1093/brain/121.1.47PubMedCrossRef

63.

Vuilleumier P, Richardson MP, Armony JL, Driver J, Dolan RJ: Distant influences of amygdala lesion on visual cortical activation during emotional face processing. [see comment]. Nat Neurosci 2004, 7:1271–1278. 10.1038/nn1341PubMedCrossRef

64.

Schutter DJ, van Honk J: The cerebellum on the rise in human emotion. Cerebellum 2005, 4:290–294. 10.1080/14734220500348584PubMedCrossRef

65.

Keren-Happuch E, Chen SH, Ho MH, Desmond JE: A meta-analysis of cerebellar contributions to higher cognition from PET and fMRI studies. Hum Brain Mapp 2014, 35:593–615. 10.1002/hbm.22194PubMedCentralCrossRef

66.

Schmahmann JD, Caplan D: Cognition, emotion and the cerebellum. Brain 2006, 129:290–292.PubMedCrossRef

67.

Stoodley CJ, Schmahmann JD, Weilburg JB, Sherman JC, Caplan D: Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage 2009, 44:489–501. 10.1016/j.neuroimage.2008.08.039PubMedCrossRef

68.

Imaizumi S, Mori K, Kiritani S, Kawashima R, Sugiura M, Fukuda H, Itoh K, Kato T, Nakamura A, Hatano K, Kojima S, Nakamura K: Vocal identification of speaker and emotion activates different brain regions. Neuroreport 1997, 8:2809–2812. 10.1097/00001756-199708180-00031PubMedCrossRef

69.

Habel U, Klein M, Kellermann T, Shah NJ, Schneider F: Same or different? Neural correlates of happy and sad mood in healthy males. Neuroimage 2005, 26:206–214. 10.1016/j.neuroimage.2005.01.014PubMedCrossRef

70.

Turner BM, Paradiso S, Marvel CL, Pierson R, Boles Ponto LL, Hichwa RD, Robinson RG: The cerebellum and emotional experience. Neuropsychologia 2007, 45:1331–1341. 10.1016/j.neuropsychologia.2006.09.023PubMedCentralPubMedCrossRef

71.

Hofer A, Siedentopf CM, Ischebeck A, Rettenbacher MA, Verius M, Felber S, Wolfgang Fleischhacker W: Sex differences in brain activation patterns during processing of positively and negatively valenced emotional words. Psychol Med 2007, 37:109–119. 10.1017/S0033291706008919PubMedCrossRef

72.

Supple WF Jr, Sebastiani L, Kapp BS: Purkinje cell responses in the anterior cerebellar vermis during Pavlovian fear conditioning in the rabbit. Neuroreport 1993, 4:975–978. 10.1097/00001756-199307000-00035PubMedCrossRef

73.

Maschke M, Schugens M, Kindsvater K, Drepper J, Kolb FP, Diener HC, Daum I, Timmann D: Fear conditioned changes of heart rate in patients with medial cerebellar lesions. J Neurol Neurosurg Psychiatry 2002, 72:116–118. 10.1136/jnnp.72.1.116PubMedCentralPubMedCrossRef

74.

Schmahmann JD: An emerging concept: the cerebellar contribution to higher function. Arch Neurol 1991, 48:1178–1187. 10.1001/archneur.1991.00530230086029PubMedCrossRef

75.

van Amelsvoort T, Schmitz N, Daly E, Deeley Q, Critchley H, Henry J, Robertson D, Owen M, Murphy KC, Murphy DG: Processing facial emotions in adults with velo-cardio-facial syndrome: Functional magnetic resonance imaging. Br J Psychiatry 2006, 189:560–561. 10.1192/bjp.bp.105.019876PubMedCrossRef

76.

Kates WR, Burnette CP, Jabs EW, Rutberg J, Murphy AM, Grados M, Geraghty M, Kaufmann WE, Pearlson GD: Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry 2001, 49:677–684. 10.1016/S0006-3223(00)01002-7PubMedCrossRef

77.

van Amelsvoort T, Daly E, Henry J, Robertson D, Ng V, Owen M, Murphy KC, Murphy DG: Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch Gen Psychiatry 2004, 61:1085–1096. 10.1001/archpsyc.61.11.1085PubMedCrossRef

78.

Andersson F, Glaser B, Spiridon M, Debbane M, Vuilleumier P, Eliez S: Impaired activation of face processing networks revealed by functional magnetic resonance imaging in 22q11.2 deletion syndrome. Biol Psychiatry 2008, 63:49–57. 10.1016/j.biopsych.2007.02.022PubMedCrossRef

79.

Gur RE, McGrath C, Chan RM, Schroeder L, Turner T, Turetsky BI, Kohler C, Alsop D, Maldjian J, Ragland JD, Gur RC: An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatr 2002, 159:1992–1999. 10.1176/appi.ajp.159.12.1992PubMedCrossRef

80.

Johnston PJ, Stojanov W, Devir H, Schall U: Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates. Eur J Neurosci 2005, 22:1221–1232. 10.1111/j.1460-9568.2005.04294.xPubMedCrossRef

81.

Quintana J, Wong T, Ortiz-Portillo E, Marder SR, Mazziotta JC: Right lateral fusiform gyrus dysfunction during facial information processing in schizophrenia. Biol Psychiatry 2003, 53:1099–1112. 10.1016/S0006-3223(02)01784-5PubMedCrossRef

82.

Blair RJR: Facial expressions, their communicatory functions and neuro-cognitive substrates. Philos Trans R Soc Lond B Biol Sci 2003, 358:561–572. 10.1098/rstb.2002.1220PubMedCentralPubMedCrossRef

83.

Deeley Q, Daly EM, Azuma R, Surguladze S, Giampietro V, Brammer MJ, Hallahan B, Dunbar RIM, Phillips ML, Murphy DGM: Changes in male brain responses to emotional faces from adolescence to middle age. Neuroimage 2008, 40:389–397. 10.1016/j.neuroimage.2007.11.023PubMedCrossRef

84.

Goodman R: The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 1997, 38:581–586. 10.1111/j.1469-7610.1997.tb01545.xPubMedCrossRef

85.

Goodman R, Ford T, Simmons H, Gatward R, Meltzer H: Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. Br J Psychiatry 2000, 177:534–539. 10.1192/bjp.177.6.534PubMedCrossRef

86.

Goodman R, Ford T, Simmons H, Gatward R, Meltzer H: Using the Strengths and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. Int Rev Psychiatry 2003, 15:166–172. 10.1080/0954026021000046128PubMedCrossRef

87.

Campbell LE, Daly E, Toal F, Stevens A, Azuma R, Catani M, Ng V, van Amelsvoort T, Chitnis X, Cutter W, Murphy DG, Murphy KC: Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 2006, 129:1218–1228. 10.1093/brain/awl066PubMedCrossRef

88.

Berument SK, Rutter M, Lord C, Pickles A, Bailey A, Starr E, Tomlins M, Papanikolauou K: Autism screening questionnaire: diagnostic validity: pre-linguistic autism diagnostic observation schedule adapted for older individuals with severe to profound mental retardation: a pilot study. Br J Psychiatry 1999, 175:444–451. 10.1192/bjp.175.5.444PubMedCrossRef

89.

Conners CK: Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiatry 1998, 7:24–30.

90.

Conners CK, Sitarenios G, Parker JD, Epstein JN: The revised Conners’ Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorml Child Psychol 1998, 26:257–268. 10.1023/A:1022602400621CrossRef

91.

APA: Diagnostic and Statistical Manual of Mental Disorders. Washington: American Psychiatric Association; 1994. ISBN 4.

92.

Wechsler D: Wechsler Intelligence Scales for Children - third edition. San Antonio, Texas: The Psychological Corporation; 1991.

93.

Russell G, Rodgers LR, Ford T: The strengths and difficulties questionnaire as a predictor of parent-reported diagnosis of autism spectrum disorder and attention deficit hyperactivity disorder. PLoS One 2013, 8:e80247. 10.1371/journal.pone.0080247PubMedCentralPubMedCrossRef

94.

Young AP, Calder AJ, Sprengelmeyer R, Ekman P: Facial Expressions of Emotion: Stimuli and Tests (FEEST). Thames Valley Test Company: Bury St Edmunds; 2002.

95.

Brammer MJ, Bullmore ET, Simmons A, Williams SC, Grasby PM, Howard RJ, Woodruff PW, Rabe-Hesketh S: Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magn Reson Imaging 1997, 15:763–770. 10.1016/S0730-725X(97)00135-5PubMedCrossRef

96.

Bullmore ET, Brammer MJ, Rabe-Hesketh S, Curtis VA, Morris RG, Williams SC, Sharma T, McGuire PK: Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Hum Brain Mapp 1999, 7:38–48. 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.0.CO;2-QPubMedCrossRef

97.

Friman O, Borga M, Lundberg P, Knutsson H: Adaptive analysis of fMRI data. Neuroimage 2003, 19:837–845. 10.1016/S1053-8119(03)00077-6PubMedCrossRef

98.

Bullmore E, Long C, Suckling J, Fadili J, Calvert G, Zelaya F, Carpenter TA, Brammer M: Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains. Hum Brain Mapp 2001, 2001:12(2).

99.

Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ: Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 1999, 18:32–42. 10.1109/42.750253PubMedCrossRef

100.

Talairach J, Tornoux P: Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme; 1988.

101.

Goodman A, Goodman R: Strengths and difficulties questionnaire as a dimensional measure of child mental health. J Am Acad Child Adolesc Psychiatry 2009, 48:400–403. 10.1097/CHI.0b013e3181985068PubMedCrossRef

102.

St Clair MC, Pickles A, Durkin K, Conti-Ramsden G: A longitudinal study of behavioral, emotional and social difficulties in individuals with a history of specific language impairment (SLI). J Commun Disord 2011, 44:186–199. 10.1016/j.jcomdis.2010.09.004PubMedCrossRef

103.

Deeley Q, Daly EM, Surguladze S, Page L, Toal F, Robertson D, Curran S, Giampietro V, Seal M, Brammer MJ, Andrew C, Murphy K, Phillips ML, Murphy DGM: An event related functional magnetic resonance imaging study of facial emotion processing in Asperger syndrome. Biol Psychiatry 2007, 62:207–217. 10.1016/j.biopsych.2006.09.037PubMedCrossRef

104.

Schmahmann JD, Weilburg JB, Sherman JC: The neuropsychiatry of the cerebellum - insights from the clinic. Cerebellum 2007, 6:254–267. 10.1080/14734220701490995PubMedCrossRef

105.

Simon TJ, Ding L, Bish JP, McDonald-McGinn DM, Zackai EH, Gee J: Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11.2 deletion syndrome: an integrative study. Neuroimage 2005, 25:169–180. 10.1016/j.neuroimage.2004.11.018PubMedCrossRef

106.

Sander D, Grafman J, Zalla T: The human amygdala: an evolved system for relevance detection. Rev Neurosci 2003, 14:303–316.PubMed

107.

Morris JS, Frith CD, Perrett DI, Rowland D, Young AW, Calder AJ, Dolan RJ: A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 1996, 383:812–815. 10.1038/383812a0PubMedCrossRef

108.

Phillips ML, Young AW, Senior C, Brammer M, Andrew C, Calder AJ, Bullmore ET, Perrett DI, Rowland D, Williams SC, Gray JA, David AS: A specific neural substrate for perceiving facial expressions of disgust. Nature 1997, 389:495–498. 10.1038/39051PubMedCrossRef

109.

Dimberg U, Petterson M, Dimberg U, Petterson M: Facial reactions to happy and angry facial expressions: evidence for right hemisphere dominance. Psychophysiology 2000, 37:693–696. 10.1111/1469-8986.3750693PubMedCrossRef

110.

Leslie KR, Johnson-Frey SH, Grafton ST: Functional imaging of face and hand imitation: towards a motor theory of empathy. Neuroimage 2004, 21:601–607. 10.1016/j.neuroimage.2003.09.038PubMedCrossRef

111.

Quintana J, Davidson T, Kovalik E, Marder SR, Mazziotta JC: A compensatory mirror cortical mechanism for facial affect processing in schizophrenia. Neuropsychopharmacology 2001, 25:915–924. 10.1016/S0893-133X(01)00304-9PubMedCrossRef

112.

Paradiso S, Johnson DL, Andreasen NC, O’Leary DS, Watkins GL, Ponto LL, Hichwa RD: Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects. Am J Psychiatr 1999, 156:1618–1629. 10.1176/ajp.156.10.1618PubMedCrossRef

113.

Pierce K, Muller RA, Ambrose J, Allen G, Courchesne E: Face processing occurs outside the fusiform ‘face area’ in autism: evidence from functional MRI. Brain 2001, 124:2059–2073. 10.1093/brain/124.10.2059PubMedCrossRef

114.

Reiman EM, Lane RD, Ahern GL, Schwartz GE, Davidson RJ, Friston KJ, Yun LS, Chen K: Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatr 1997, 154:918–925.PubMedCrossRef

115.

Jackson PL, Meltzoff AN, Decety J, Jackson PL, Meltzoff AN, Decety J: How do we perceive the pain of others? A window into the neural processes involved in empathy. Neuroimage 2005, 24:771–779. 10.1016/j.neuroimage.2004.09.006PubMedCrossRef

116.

Singer T, Seymour B, O’Doherty J, Kaube H, Dolan RJ, Frith CD: Empathy for pain involves the affective but not sensory components of pain. [see comment]. Science 2004, 303:1157–1162. 10.1126/science.1093535PubMedCrossRef

117.

Beauregard M, Leroux JM, Bergman S, Arzoumanian Y, Beaudoin G, Bourgouin P, Stip E: The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm. Neuroreport 1998, 9:3253–3258. 10.1097/00001756-199810050-00022PubMedCrossRef

118.

Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF: Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996, 67:468–472. Publisher Full Text 10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-GPubMedCrossRef

119.

Bearden CE, Jawad AF, Lynch DR, Monterossso JR, Sokol S, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ: Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome. Child Neuropsychol 2005, 11:109–117. 10.1080/09297040590911239PubMedCentralPubMedCrossRef

120.

Bearden CE, Jawad AF, Lynch DR, Sokol S, Kanes SJ, McDonald-McGinn DM, Saitta SC, Harris SE, Moss E, Wang PP, Zackai E, Emanuel BS, Simon TJ: Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatr 2004, 161:1700–1702. 10.1176/appi.ajp.161.9.1700PubMedCrossRef

121.

Fallgatter AJ, Lesch KP: 22q11.2 deletion syndrome as a natural model for COMT haploinsufficiency-related dopaminergic dysfunction in ADHD. Int J Neuropsychopharmacol 2007, 10:295–299.PubMedCrossRef

122.

Gothelf D, Hoeft F, Hinard C, Hallmayer JF, Stoecker JV, Antonarakis SE, Morris MA, Reiss AL: Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome. Hum Brain Mapp 2007, 28:533–542. 10.1002/hbm.20405PubMedCrossRef

123.

Dalton KM, Nacewicz BM, Alexander AL, Davidson RJ: Gaze-fixation, brain activation, and amygdala volume in unaffected siblings of individuals with autism. Biol Psychiatry 2007, 61:512–520. 10.1016/j.biopsych.2006.05.019PubMedCrossRef

124.

Kaiser MD, Hudac CM, Shultz S, Lee SM, Cheung C, Berken AM, Deen B, Pitskel NB, Sugrue DR, Voos AC, Saulnier CA, Ventola P, Wolf JM, Klin A, Vander Wyk BC, Pelphrey KA: Neural signatures of autism. Proc Natl Acad Sci U S A 2010, 107:21223–21228. 10.1073/pnas.1010412107PubMedCentralPubMedCrossRef

125.

Lazarus RS: Cognition and motivation in emotion. Am Psychol 1991, 46:352–367.PubMedCrossRef

126.

Sprengelmeyer R, Rausch M, Eysel UT, Przuntek H: Neural structures associated with recognition of facial expressions of basic emotions. Proc Biol Sci 1998, 265:1927–1931. 10.1098/rspb.1998.0522PubMedCentralPubMedCrossRef

Titel: An fMRI study of facial emotion processing in children and adolescents with 22q11.2 deletion syndrome
verfasst von: Rayna Azuma
Quinton Deeley
Linda E Campbell
Eileen M Daly
Vincent Giampietro
Michael J Brammer
Kieran C Murphy
Declan GM Murphy
Publikationsdatum: 01.12.2015
Verlag: BioMed Central
Erschienen in: Journal of Neurodevelopmental Disorders / Ausgabe 1/2015
Print ISSN: 1866-1947
Elektronische ISSN: 1866-1955
DOI: https://doi.org/10.1186/1866-1955-7-1

Neu im Fachgebiet Psychiatrie

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Electronic supplementary material

Competing interests

Authors’ contributions

Background

Methods

Participants

Functional neuroimaging task

Image acquisition

Neuroimaging data analysis

Individual brain activation maps

Group brain activation maps

Within-group linear trend analysis

Between-group and group-by-intensity interaction analysis

Post hoc analysis

Correlations between brain activity during facial emotion processing and social behaviour

Results

Demographic details and behavioural results

Face versus fixation cross contrasts

Within group linear trend analysis

Between-group and group-by-intensity interaction analysis

Post hoc analysis

Correlation with behavioural measures

Discussion

Conclusions

Authors’ information

Acknowledgements

Competing interests

Authors’ contributions

Electronic supplementary material

Weitere Artikel der Ausgabe 1/2015

Autism diagnosis differentiates neurophysiological responses to faces in adults with tuberous sclerosis complex

Face scanning and spontaneous emotion preference in Cornelia de Lange syndrome and Rubinstein-Taybi syndrome

Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms

Speech motor planning and execution deficits in early childhood stuttering

There is variability in the attainment of developmental milestones in the CDKL5 disorder

High rates of parkinsonism in adults with autism

Neu im Fachgebiet Psychiatrie

Darf man die Behandlung eines Neonazis ablehnen?

Wartezeit nicht kürzer, aber Arbeit flexibler

Chirurginnen und Chirurgen sind stark suizidgefährdet

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern